Topic

Claude Science

Every THE D[AI]LY BRIEF article on Claude Science — enterprise AI analysis, benchmarks, vendor comparisons, and ROI frameworks for technology and business leaders. Updated as new coverage publishes.

AI Drug Discovery

3 AI Giants, $3.25B Market, Zero FDA Approvals

Anthropic launches Claude Science and hires Nobel laureate John Jumper. But AI drug discovery's 80% Phase 1 rate drops to 40% in Phase 2. What pharma CTOs and CFOs need to know before betting billions.

July 6, 2026 · 15 min read